Viewing data from:

ANASTROZOLE

ANDA

ANASTROZOLE | A078058 | TEVA PHARMACEUTICALS USA

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ARIMIDEX(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Anastrozole (2023)

Total Spending

$44.1M

Total Claims

1,612,733

Beneficiaries

409,158

Avg Cost/Unit

$0.42

Spending Trend

$33.0M(2019)→$38.0M(2020)→$41.9M(2021)→$40.5M(2022)→$44.1M(2023)

YoY Change:+5.5%

5yr CAGR:+3.0%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain13 active DMFs12 inactive

13 active API suppliers hold Drug Master Files for this ingredient.

SCINOPHARM TAIWAN LTDANASTROZOLE USP

DMF 183352005

TAPI NL BVANASTROZOLE

DMF 190342005

NATCO PHARMA LTDANASTROZOLE

DMF 196872006

CIPLA LTDANASTROZOLE USP

DMF 197482008

DR REDDYS LABORATORIES LTDANASTROZOLE USP

DMF 201412007

FORMOSA LABORATORIES INCANASTROZOLE

DMF 202822007

EXCELLA GMBH AND CO KGANASTROZOLE

DMF 203382007

SUN PHARMACEUTICAL INDUSTRIES LTDANASTROZOLE USP

DMF 219012008

HETERO LABS LTDANASTROZOLE USP

DMF 222312008

APOTEX INCANASTROZOLE USP

DMF 233262009

SYNTHIMED LABS PRIVATE LTDANASTROZOLE USP

DMF 253082011

SHILPA PHARMA LIFESCIENCES LTDANASTROZOLE USP

DMF 296542015

WANYANG HENGSHUI PHARMACEUTICAL CO LTDANASTROZOLE

DMF 403052024

ALCAMI WISCONSIN CORPInactiveANASTROZOLE

DMF 190252005

TAI HENG INDUSTRY CO LTDInactiveANASTROZOLE

DMF 194962006

WAVELENGTH ENTERPRISES LTDInactiveANASTROZOLE

DMF 198082006

USV LTDInactiveANASTROZOLE

DMF 204692007

FRESENIUS KABI ONCOLOGY LTDInactiveANASTROZOLE

DMF 206602007

CADILA HEALTHCARE LTDInactiveANASTROZOLE

DMF 223232008

SHILPA MEDICARE LTDInactiveANASTROZOLE

DMF 231232009

EMCURE PHARMACEUTICALS LTDInactiveANASTROZOLE USP

DMF 254842011

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactiveANASTROZOLE USP

DMF 258972012

SICHUAN XIELI PHARMACEUTICAL CO LTDInactiveANASTROZOLE

DMF 262022012

MAC CHEM PRODUCTS INDIA PVT LTDInactiveANASTROZOLE USP

DMF 265812012

ASYMCHEM LABORATORIES TIANJIN CO LTDInactiveANASTROZOLE

DMF 277502013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 30, 2010	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 28, 2010

No patent or exclusivity listings for this strength.